o - Search

Clinical Trials

• O(6)-benzylguanine and Carmustine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002604 - Completed
  unspecified adult solid tumor, protocol specific
  
• O(6)-benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003613 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
  
• O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00436436 - Recruiting
  Brain and Central Nervous System Tumors
  
• O(6)-benzylguanine in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00002971 - Completed
  adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
  
• O6-benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00004892 - Completed
  Adult Oligodendroglioma; recurrent adult brain tumor; adult glioblastoma multiforme; adult ependymoma; adult anaplastic astrocytoma; ...
  
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
  ClinicalTrials.gov Identifier: NCT00003765 - Active, not recruiting
  recurrent childhood brain stem glioma; childhood choroid plexus tumor; recurrent childhood visual pathway glioma; ...
  
• O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004072 - Completed
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00005066 - Active, not recruiting
  stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma
  
• O6-benzylguanine and Carmustine in Treating Patients with Unresectable Locally Recurrent or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005961 - Completed
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
  ClinicalTrials.gov Identifier: NCT00275002 - Recruiting
  Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Brain Tumor; High-Grade Childhood Cerebral Astrocytoma; ...
  
• O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003766 - Completed
  unspecified adult solid tumor, protocol specific
  
• OASIS Mechanism of Action
  ClinicalTrials.gov Identifier: NCT00570141 - Enrolling by invitation
  Diabetic Foot Ulcers; Venous Stasis Ulcers
  
• OASIS STUDY( Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)
  ClinicalTrials.gov Identifier: NCT00281034 - Completed
  Stroke
  
• Oasys vs. Extreme H20 Xtra 59
  ClinicalTrials.gov Identifier: NCT00477763 - Recruiting
  Dry Eye
  
• Oatmeal and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00401453 - Recruiting
  Diabetes Mellitus Type 2; Insulin Resistance
  
• Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00538187 - Not yet recruiting
  Lymphoma
  
• Obatoclax Mesylate and Topotecan in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00521144 - Recruiting
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Obatoclax Mesylate, Fludarabine and Rituximab in Previously Treated Patients With B-CLL
  ClinicalTrials.gov Identifier: NCT00574938 - Recruiting
  Chronic Lymphocytic Leukemia
  
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
  ClinicalTrials.gov Identifier: NCT00577031 - Not yet recruiting
  Colorectal Cancer
  
• Obese Hypertension Study
  ClinicalTrials.gov Identifier: NCT00289887 - Active, not recruiting
  Hypertension
  
• Obese Patients with or without Comorbidities
  ClinicalTrials.gov Identifier: NCT00029861 - Completed
  Obesity; Weight Loss
  
• Obese Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00029848 - Completed
  Obesity; Diabetes Mellitus, Non-Insulin-Dependent; Obesity in Diabetes
  
• Obese Patients with Untreated Dyslipidemias
  ClinicalTrials.gov Identifier: NCT00029835 - Completed
  Obesity; Dyslipidemia
  
• Obesity and Asthma:a Specific Phenotype
  ClinicalTrials.gov Identifier: NCT00532363 - Active, not recruiting
  Obesity; Asthma
  
• Obesity and Diabetes Prevention Through Science Enrichment
  ClinicalTrials.gov Identifier: NCT00541879 - Recruiting
  Type 2 Diabetes; Obesity
  
• Obesity and Free Fatty Acid Flux
  ClinicalTrials.gov Identifier: NCT00074945 - Recruiting
  Obesity
  
• Obesity and Nonalcoholic Fatty Liver Disease
  ClinicalTrials.gov Identifier: NCT00262964 - Recruiting
  Non-Alcoholic Fatty Liver Disease
  
• Obesity and Weight Loss on Reproductive Function
  ClinicalTrials.gov Identifier: NCT00143078 - Recruiting
  Obesity; Reproductive System
  
• Obesity Assessment and Education Through the Internet
  ClinicalTrials.gov Identifier: NCT00149682 - Completed
  Obesity
  
• Obesity Intervention "Obeldicks" for Obese Children, Adolescents and Their Parents
  ClinicalTrials.gov Identifier: NCT00435734 - Recruiting
  Obesity
  
• Obesity Prevention after Smoking Cessation in Menopause
  ClinicalTrials.gov Identifier: NCT00064961 - Completed
  Obesity; Menopause
  
• Obesity Prevention for Pre-Adolescents
  ClinicalTrials.gov Identifier: NCT00185978 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Obesity Prevention in African American School Children
  ClinicalTrials.gov Identifier: NCT00061165 - Completed
  Obesity
  
• Obesity Treatment in a Managed Care Setting
  ClinicalTrials.gov Identifier: NCT00062985 - Completed
  Obesity; Weight Loss
  
• Obesity, Physical Inactivity or Dietary Fat ?
  ClinicalTrials.gov Identifier: NCT00434265 - Not yet recruiting
  Obesity
  
• Obesity, Weight Loss, and Cardiovascular Disease Risk
  ClinicalTrials.gov Identifier: NCT00186459 - Recruiting
  Obesity
  
• Objective Evaluation of Proximal Ischemia
  ClinicalTrials.gov Identifier: NCT00152737 - Recruiting
  Intermittent Claudication; Peripheral Vascular Diseases
  
• Objective Evaluation of Shoulder Pathology and Surgery
  ClinicalTrials.gov Identifier: NCT00500630 - Completed
  Glenohumeral Osteoarthritis; Rotator Cuff Disease
  
• Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
  ClinicalTrials.gov Identifier: NCT00567177 - Recruiting
  Treatment of Dry Eye Disease
  
• Objective Sleep Disturbances in Orthostatic Intolerance
  ClinicalTrials.gov Identifier: NCT00581022 - Recruiting
  Postural Tachycardia Syndrome; Chronic Orthostatic Intolerance
  
• Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
  ClinicalTrials.gov Identifier: NCT00070343 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma
  
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00047229 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
  ClinicalTrials.gov Identifier: NCT00060112 - Suspended
  adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma
  
• Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00017589 - Active, not recruiting
  recurrent adult acute myeloid leukemia
  
• Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00091078 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Oblimersen and Rituximab in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00054639 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Oblimersen in Treating Patients With Metastatic or Recurrent Merkel Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00079131 - Completed
  recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma; stage III Merkel cell carcinoma
  
• Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00021190 - No longer recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00062244 - Completed
  Waldenstrom's Macroglobulinemia
  
• Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00039481 - Completed
  cardiac toxicity; unspecified childhood solid tumor, protocol specific
  
• Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00063934 - Active, not recruiting
  stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
  
• Oblimersen Plus Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00049192 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00039117 - Active, not recruiting
  untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ...
  
• Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00086944 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma
  
• Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00070083 - Completed
  contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Observation and Evaluation of Chewing Velocity Changes on Soft Food Chewing Efficiency
  ClinicalTrials.gov Identifier: NCT00172692 - Completed
  Healthy; Mastication
  
• Observation and Prediction of Complications After Coronary Angiography
  ClinicalTrials.gov Identifier: NCT00259194 - Active, not recruiting
  Coronary Arteriosclerosis; Myocardial Ischemia
  
• Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00274950 - Recruiting
  Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer
  
• Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
  ClinicalTrials.gov Identifier: NCT00400907 - Active, not recruiting
  Long-Term Effects Secondary to Cancer Therapy in Adults; Lymphoma
  
• Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
  ClinicalTrials.gov Identifier: NCT00001826 - Completed
  HIV Infection
  
• Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section
  ClinicalTrials.gov Identifier: NCT00544947 - Not yet recruiting
  Respiratory Depression
  
• Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
  ClinicalTrials.gov Identifier: NCT00258453 - Active, not recruiting
  Brain and Central Nervous System Tumors; Long-Term Effects Secondary to Cancer Therapy in Children; Perioperative/Postoperative Complications; Psychosocial Effects/Treatment; Quality of Life; Weight Changes
  
• Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
  ClinicalTrials.gov Identifier: NCT00416559 - Active, not recruiting
  Long-Term Effects Secondary to Cancer Therapy in Children; Neuroblastoma
  
• Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
  ClinicalTrials.gov Identifier: NCT00027846 - Active, not recruiting
  childhood supratentorial ependymoma; newly diagnosed childhood ependymoma; childhood infratentorial ependymoma
  
• Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00003375 - Active, not recruiting
  Adult Oligodendroglioma; adult noninfiltrating astrocytoma; adult infiltrating astrocytoma
  
• Observation or Radical Treatment in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00499174 - Recruiting
  Prostate Cancer
  
• Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
  ClinicalTrials.gov Identifier: NCT00193661 - Completed
  Primary or Secondary Hypogonadism; Constitutional Delay in Growth and Puberty (CDGP)
  
• Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00410631 - Recruiting
  Brain and Central Nervous System Tumors
  
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00346164 - Recruiting
  Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
  
• Observational Aspirin Use and CVD in the Physicians' Health Study
  ClinicalTrials.gov Identifier: NCT00005493 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Cerebrovascular Accident
  
• Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
  ClinicalTrials.gov Identifier: NCT00316732 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
  ClinicalTrials.gov Identifier: NCT00433030 - Recruiting
  HIV Infections
  
• Observational Cohort Study of Sodium, Weight and CVD
  ClinicalTrials.gov Identifier: NCT00006308 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Observational Cohort Study of TachoSil
  ClinicalTrials.gov Identifier: NCT00285623 - Active, not recruiting
  Blood Loss, Surgical
  
• Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
  ClinicalTrials.gov Identifier: NCT00388947 - Recruiting
  Vaginal Prolapse
  
• Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury
  ClinicalTrials.gov Identifier: NCT00498498 - Recruiting
  Cerebrovascular Trauma; Neurohormones; Cellular Apoptosis; Endothelin System
  
• Observational FAP Registry Study
  ClinicalTrials.gov Identifier: NCT00151476 - Recruiting
  Adenomatous Polyposis Coli
  
• Observational Learning in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00083642 - Active, not recruiting
  
  
• Observational Non-Interventional Study (Anwendungsbeobachtung) With Aptivus? (Tipranavir) in HIV-Infected Patients.
  ClinicalTrials.gov Identifier: NCT00531206 - Recruiting
  HIV Infections
  
• Observational Non-Interventional Study (Anwendungsbeobachtung) With Telmisartan in High-Risk Hypertensives
  ClinicalTrials.gov Identifier: NCT00539487 - Recruiting
  Hypertension; Obesity
  
• Observational Non-Interventional Study With Spiriva in COPD Patients With Exercise-Induced Dyspnoea
  ClinicalTrials.gov Identifier: NCT00540163 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Observational Non-Interventional Study With Viramune? in Combination With Truvada? in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00543803 - Recruiting
  HIV Infections
  
• Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
  ClinicalTrials.gov Identifier: NCT00358813 - Recruiting
  Renal Impairment
  
• Observational Safety Study of Enbrel for Treatment of Psoriasis
  ClinicalTrials.gov Identifier: NCT00322439 - Completed
  Psoriasis
  
• Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
  ClinicalTrials.gov Identifier: NCT00359177 - Completed
  Renal Impairment
  
• Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
  ClinicalTrials.gov Identifier: NCT00242840 - Completed
  HIV Infections
  
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00259909 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
  ClinicalTrials.gov Identifier: NCT00549952 - Recruiting
  Oral Mucositis
  
• Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00331448 - Active, not recruiting
  HIV Infections; Lipodystrophy; Diabetes; Hyperlipidemia; Atherosclerosis
  
• Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  ClinicalTrials.gov Identifier: NCT00119405 - Recruiting
  HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders
  
• Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide
  ClinicalTrials.gov Identifier: NCT00202657 - Active, not recruiting
  Parkinson's Disease; Pergolide
  
• Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
  ClinicalTrials.gov Identifier: NCT00514098 - Not yet recruiting
  HIV Infections
  
• Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
  ClinicalTrials.gov Identifier: NCT00321438 - Terminated
  HIV Infections
  
• Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
  ClinicalTrials.gov Identifier: NCT00550069 - Not yet recruiting
  Respiratory Distress; Hypoglycemia; Feeding Intolerance; Jaundice; Hypothermia; Developmental Delay
  
• Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
  ClinicalTrials.gov Identifier: NCT00569907 - Recruiting
  Diabetes Mellitus Type 2
  
• Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients
  ClinicalTrials.gov Identifier: NCT00338234 - Recruiting
  Anemia; Intensive Care; Cardiac Surgery
  
• Observational Study of Lamotrigine
  ClinicalTrials.gov Identifier: NCT00299793 - Completed
  Epilepsy
  
• Observational Study of Pergolide Mesylate and Cardiac Valvulopathy
  ClinicalTrials.gov Identifier: NCT00311532 - Completed
  Parkinson Disease
  
• Observational Study of Prosthetic Tissue Aortic and Mitral Heart Valve
  ClinicalTrials.gov Identifier: NCT00329667 - Active, not recruiting
  Valvular Heart Disease
  
• Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
  ClinicalTrials.gov Identifier: NCT00258869 - Recruiting
  Sepsis; Septicemia; Sepsis Syndrome; Shock, Septic; Pneumonia
  
• Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.
  ClinicalTrials.gov Identifier: NCT00158717 - Active, not recruiting
  Hepatitis B
  
• Observational Study of the Prognosis in Treated Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00225030 - Completed
  Hypertension
  
• Observational Study of the Remodelling Process Following Myocardial Infarct
  ClinicalTrials.gov Identifier: NCT00338156 - Completed
  Heart Failure; Myocardial Infarct
  
• Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00219934 - Recruiting
  HIV Infections
  
• Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients
  ClinicalTrials.gov Identifier: NCT00557141 - Not yet recruiting
  Asthma
  
• Observational Study to Determine Impact of Multiple NAb Tests on Treatment Patterns Compared to the Usual Care of MS Patients Receiving High-Dose IFN Therapy.
  ClinicalTrials.gov Identifier: NCT00336557 - Recruiting
  Multiple Sclerosis
  
• Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe
  ClinicalTrials.gov Identifier: NCT00457275 - Completed
  Hypercholesterolemia
  
• Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  ClinicalTrials.gov Identifier: NCT00244465 - Recruiting
  Narcolepsy
  
• Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
  ClinicalTrials.gov Identifier: NCT00347217 - Recruiting
  Hypercholesteremia
  
• Observational Trial With Enbrel
  ClinicalTrials.gov Identifier: NCT00488475 - Recruiting
  Rheumatoid Arthritis
  
• Observational Trial With Leios/Alesse
  ClinicalTrials.gov Identifier: NCT00481650 - Completed
  Contraceptives, Oral, Combined
  
• Observing Patients with Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00005020 - Active, not recruiting
  HIV Infections
  
• Obstetrics and Periodontal Therapy (OPT) Study
  ClinicalTrials.gov Identifier: NCT00066131 - Active, not recruiting
  Periodontitis; Infant, Premature
  
• Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress
  ClinicalTrials.gov Identifier: NCT00177892 - Recruiting
  Obstructive Sleep Apnea; Metabolic Syndrome X
  
• Obstructive Sleep Apnea Syndrome in Glaucoma
  ClinicalTrials.gov Identifier: NCT00313092 - Recruiting
  Obstructive Sleep Apnoe Syndrome; Glaucoma
  
• Obtain a Good Blood Glucose Control With the Paradigm Real Time System
  ClinicalTrials.gov Identifier: NCT00441129 - Recruiting
  Type 1 Diabetes
  
• Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.
  ClinicalTrials.gov Identifier: NCT00200109 - Active, not recruiting
  Chronic Migraine Headache
  
• Occipital Nerve Stimulation to Treat Chronic Headaches
  ClinicalTrials.gov Identifier: NCT00205894 - Active, not recruiting
  Headache Disorders
  
• Occluded Artery Trial (OAT)
  ClinicalTrials.gov Identifier: NCT00004562 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Heart Failure, Congestive; Heart Failure
  
• Occupation and Asthma in an Urban Low Income Population
  ClinicalTrials.gov Identifier: NCT00014820 - Completed
  Asthma; Lung Diseases
  
• Occupational Therapy to Treat Children Who Over or Under React to Their Environment
  ClinicalTrials.gov Identifier: NCT00006507 - Completed
  Sensory Disorders
  
• Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the Highly Active Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00516581 - Completed
  Pneumocystis Pneumonia; HIV Infections
  
• OCD Among Patients With Burns
  ClinicalTrials.gov Identifier: NCT00294983 - Suspended
  Obsessive-Compulsive Dosorder; Burns
  
• OCSTUD Docetaxel+Cisplatin+Cyclophosphamide Versus Docetaxel+Carboplatin in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00452985 - Active, not recruiting
  Ovarian Neoplasms
  
• OCT for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00581503 - Enrolling by invitation
  Lung Cancer; Pleural Cancer; Prostate Cancer
  
• Octanol to Treat Essential Tremor
  ClinicalTrials.gov Identifier: NCT00080366 - Completed
  Essential Tremor
  
• Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00008073 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
  ClinicalTrials.gov Identifier: NCT00569127 - Not yet recruiting
  Head and Neck Cancer; Islet Cell Tumor; Neuroendocrine Carcinoma of the Skin
  
• Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004895 - Completed
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer
  
• Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00332696 - Active, not recruiting
  Peritoneal Neoplasms; Intestinal Obstruction; Carcinomatosis
  
• Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003057 - Active, not recruiting
  Colon Cancer; Diarrhea; Rectal Cancer
  
• Octreotide Efficacy and Safety in First-Line Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00171886 - Suspended
  Acromegaly
  
• Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
  ClinicalTrials.gov Identifier: NCT00033605 - Active, not recruiting
  adult solid tumor; Diarrhea; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; male reproductive cancer
  
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00075868 - Active, not recruiting
  Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer
  
• Octreotide in Severe Polycystic Liver Disease
  ClinicalTrials.gov Identifier: NCT00426153 - Recruiting
  Polycystic Kidney, Autosomal Dominant; Hepatomegaly; Liver Diseases; Kidney, Polycystic; Abdominal Pain
  
• Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00006269 - Active, not recruiting
  recurrent colon cancer; Diarrhea; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Octreotide in Treating Patients With Cancer-Related Malignant Ascites
  ClinicalTrials.gov Identifier: NCT00182754 - Recruiting
  unspecified adult solid tumor, protocol specific; malignant ascites
  
• Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00257426 - Active, not recruiting
  Liver Cancer
  
• Octreotide Therapy in Children With Prader-Willi Syndrome (PWS)
  ClinicalTrials.gov Identifier: NCT00399893 - Recruiting
  Prader-Willi Syndrome
  
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
  ClinicalTrials.gov Identifier: NCT00003283 - Active, not recruiting
  recurrent malignant thymoma; invasive malignant thymoma
  
• Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002967 - Completed
  stage I breast cancer; invasive ductal breast carcinoma; stage II breast cancer
  
• Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment with Dorzolamide
  ClinicalTrials.gov Identifier: NCT00152932 - Recruiting
  Laser-Doppler Flowmetry
  
• Ocular Hypertension Treatment Study (OHTS)
  ClinicalTrials.gov Identifier: NCT00000125 - Active, not recruiting
  Ocular Hypertension; Glaucoma
  
• Ocular Hypotensive Efficacy of AR-102
  ClinicalTrials.gov Identifier: NCT00523250 - Recruiting
  Glaucoma
  
• Ocular Ischemic Syndrome
  ClinicalTrials.gov Identifier: NCT00403195 - Recruiting
  Retinal Degeneration; Diabetic Retinopathy
  
• Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00356850 - Completed
  Eye Infections, Bacterial
  
• Ocular Pulse Amplitude And Choroidal Laser Doppler Flowmetry
  ClinicalTrials.gov Identifier: NCT00409110 - Recruiting
  Healthy
  
• Ocular Surface Changes in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00345280 - Not yet recruiting
  Eye Manifestations
  
• Ocular Tolerance and IOP Effects of Zylet vs Tobradex
  ClinicalTrials.gov Identifier: NCT00532961 - Completed
  Ocular Inflammation
  
• Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00357292 - Completed
  Eye Infections, Bacterial
  
• Oculusgen (Ologen) Collagen Matrix Safety and Effective Comparision With MMC in Glaucoma Surgery
  ClinicalTrials.gov Identifier: NCT00538590 - Recruiting
  Open Angle Glaucoma
  
• Oculusgen (Ologen) Glaucoma MMC Control in Estonia
  ClinicalTrials.gov Identifier: NCT00524758 - Recruiting
  Open Angle Glaucoma; Angle Closure Glaucoma; Uveitis Glaucoma; Young Age Glaucoma; Neovascular Glaucoma; High Risk Patient
  
• OculusGen-Glaucoma Historical Control Study in Taiwan
  ClinicalTrials.gov Identifier: NCT00406822 - Recruiting
  Glaucoma
  
• OculusGen-Phacotrabeculectomy Historical Control Study in India
  ClinicalTrials.gov Identifier: NCT00477685 - Recruiting
  Glaucoma; Cataract
  
• OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00449722 - Completed
  Ulcerative Colitis
  
• Odense Androgen Study
  ClinicalTrials.gov Identifier: NCT00150163 - Active, not recruiting
  Bone Diseases; Lipid and glucose metabolism
  
• Odense Androgen Study in the Elderly
  ClinicalTrials.gov Identifier: NCT00155961 - Completed
  Bone Diseases; Metabolic Syndrome
  
• Odiparcil For The Prevention Of Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00244725 - Active, not recruiting
  Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism
  
• Odiparcil QT Definitive Study
  ClinicalTrials.gov Identifier: NCT00437242 - Terminated
  Atrial Fibrillation
  
• ODYSSEY Study: Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00174863 - Completed
  Prostatic Neoplasm
  
• Oestrogen Withdrawal in Hypopituitary Women
  ClinicalTrials.gov Identifier: NCT00572390 - Completed
  Hypopituitarism
  
• Ofatumumab (Humax-CD20) With CHOP in FL Patients
  ClinicalTrials.gov Identifier: NCT00494780 - Recruiting
  Follicular Lymphoma
  
• Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
  ClinicalTrials.gov Identifier: NCT00410163 - Recruiting
  B-Cell Chronic Lymphocytic Leukemia
  
• Off Label Use of INFLIXIMAB in Adult Patients With Severe Eosinophilic Esophagitis
  ClinicalTrials.gov Identifier: NCT00523354 - Completed
  Esophagitis
  
• Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy
  ClinicalTrials.gov Identifier: NCT00344617 - Active, not recruiting
  Choroidal Neovascularisation; Polypoidal Choroidal Vasculopathy
  
• Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00380679 - Active, not recruiting
  High Risk for Serious Influenza; High Risk for Pneumonia
  
• Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study
  ClinicalTrials.gov Identifier: NCT00258973 - Completed
  Atherosclerosis
  
• Office-Based Asthma Screening Intervention
  ClinicalTrials.gov Identifier: NCT00156468 - Completed
  Asthma
  
• Official Record of Patients Diagnosed with Lymphangioleiomyomatosis (LAM)
  ClinicalTrials.gov Identifier: NCT00001869 - Completed
  Leiomyomatosis
  
• Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate
  ClinicalTrials.gov Identifier: NCT00480376 - Not yet recruiting
  Infection
  
• OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients with Neuronopathic Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00041535 - Active, not recruiting
  Gaucher Disease
  
• OGT Spray in the Management of Xerostomia in the Elderly
  ClinicalTrials.gov Identifier: NCT00350350 - Terminated
  Xerostomia
  
• OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00471432 - Completed
  Bladder Cancer; Breast Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00258375 - Active, not recruiting
  Breast Cancer
  
• Olanzapine Augmentation Therapy in Treatment-Resistant Depression: a Double-Blind Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00273624 - Recruiting
  Therapy-Resistant Depression
  
• Olanzapine Compared to Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00094549 - Completed
  Bipolar Disorder
  
• Olanzapine in Patients With Advanced Cancer and Weight Loss
  ClinicalTrials.gov Identifier: NCT00489593 - Recruiting
  Advanced Cancer; Weight Loss
  
• Olanzapine in Patients with Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00091650 - Completed
  Borderline Personality Disorder
  
• Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
  ClinicalTrials.gov Identifier: NCT00182507 - Completed
  Trichotillomania
  
• Olanzapine in the Treatment of Patients With Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00260962 - Recruiting
  Anorexia Nervosa
  
• Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00320489 - Recruiting
  Schizophrenia
  
• Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
  ClinicalTrials.gov Identifier: NCT00190892 - Completed
  Bipolar Disorder
  
• Olanzapine Treatment of Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00510146 - Recruiting
  Depression, Bipolar
  
• Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00034580 - Completed
  Bipolar Disorder
  
• Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00034801 - Completed
  Depression; Schizophrenia; Schizoaffective Disorder
  
• Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00036088 - Completed
  Schizophrenia
  
• Olanzapine versus Aripiprazole in the Treatment of Acutely Ill Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00103571 - Completed
  Schizophrenia
  
• Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
  ClinicalTrials.gov Identifier: NCT00179231 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00485680 - Completed
  Bipolar Disorder
  
• Olanzapine versus Placebo in the Treatment of Adolescents with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00051298 - Completed
  Schizophrenia
  
• Olanzapine Versus Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00050206 - Completed
  Bipolar Disorder
  
• Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
  ClinicalTrials.gov Identifier: NCT00485771 - Completed
  Bipolar Disorder
  
• Older Adult Training Study With Creatine and CLA
  ClinicalTrials.gov Identifier: NCT00473902 - Completed
  Sarcopenia
  
• Older Men and Testosterone
  ClinicalTrials.gov Identifier: NCT00119483 - Active, not recruiting
  Hypogonadism
  
• OLES
  ClinicalTrials.gov Identifier: NCT00172133 - Active, not recruiting
  Osteoporosis
  
• Olestra Containing Foods and Weight Loss and Weight Maintenance
  ClinicalTrials.gov Identifier: NCT00198965 - Completed
  Obesity
  
• Oligodendrocyte Progenitor Cell Culture From Human Brain
  ClinicalTrials.gov Identifier: NCT00283023 - Not yet recruiting
  Demyelinating Diseases
  
• Olive Oil With Omega 3 to Treat Stasis Dermatitis
  ClinicalTrials.gov Identifier: NCT00421161 - Not yet recruiting
  Dermatitis
  
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00139698 - Completed
  Essential Hypertension
  
• Olmesartan and an Add-on Treatment in Patients With Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00311155 - Recruiting
  Essential Hypertension
  
• OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
  ClinicalTrials.gov Identifier: NCT00134160 - Active, not recruiting
  Aged; Hypertension; Diabetes Mellitus Type 2; Cardiovascular Diseases
  
• Olmesartan as an Add-on to Amlodipine in Hypertension
  ClinicalTrials.gov Identifier: NCT00220233 - Completed
  Essential Hypertension
  
• Olmesartan in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00185172 - Active, not recruiting
  Essential Hypertension
  
• Olmesartan Medoxomil and Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00362960 - Completed
  Type 2 Diabetes Mellitus; Diabetic Nephropathy; Proteinuria; Renal Disease
  
• Olmesartan Medoxomil in Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00185185 - Completed
  Essential Hypertension; Atherosclerotic Cardiovascular Disease
  
• Olmesartan Medoxomil in Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00185159 - Active, not recruiting
  Diabetes Mellitus, Type 2; Cardiovascular Disease; Kidney Disease
  
• Olmesartan Medoxomil in Hypertension and Renal Impairment
  ClinicalTrials.gov Identifier: NCT00151827 - Completed
  Essential Hypertension; Renal impairment
  
• Olmesartan Pediatric Pharmacokinetic (PK) Study
  ClinicalTrials.gov Identifier: NCT00151814 - Recruiting
  Hypertension
  
• Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00441350 - Not yet recruiting
  Hypertension
  
• Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital
  ClinicalTrials.gov Identifier: NCT00321035 - Active, not recruiting
  Glaucoma; Pterygium
  
• Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital
  ClinicalTrials.gov Identifier: NCT00320762 - Active, not recruiting
  Glaucoma; Pterygium
  
• Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
  ClinicalTrials.gov Identifier: NCT00320957 - Completed
  Glaucomas; Pterygium
  
• Ologen (OculusGen)-Glaucoma Case Control Trial in India
  ClinicalTrials.gov Identifier: NCT00448929 - Recruiting
  Glaucoma
  
• Ologen (OculusGen)-Glaucoma MMC Control in Pakistan
  ClinicalTrials.gov Identifier: NCT00472810 - Recruiting
  Glaucoma; Trabeculectomy
  
• Ologen (OculusGen)-Glaucoma MMC Control Trial in India
  ClinicalTrials.gov Identifier: NCT00449098 - Recruiting
  Glaucoma
  
• Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital
  ClinicalTrials.gov Identifier: NCT00478790 - Recruiting
  Glaucomas; Pterygium
  
• Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00331500 - Active, not recruiting
  Allergic Conjunctivitis
  
• Oltipraz in the Prevention of Lung Cancer in People Who Smoke
  ClinicalTrials.gov Identifier: NCT00006457 - Active, not recruiting
  Small Cell Lung Cancer; prevention of lung cancer; Non-small cell lung cancer
  
• Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
  ClinicalTrials.gov Identifier: NCT00296153 - Recruiting
  Human Immunodeficiency Virus; Ischemic Heart Disease
  
• Omacor and Placebo in Carotid Plaque Stability
  ClinicalTrials.gov Identifier: NCT00294216 - Completed
  Cardiovascular Disease
  
• Omacor for Perimenopausal Depression
  ClinicalTrials.gov Identifier: NCT00517972 - Recruiting
  Depression
  
• Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00328536 - Not yet recruiting
  Atherosclerosis; Type 2 Diabetes Mellitus
  
• Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
  ClinicalTrials.gov Identifier: NCT00257283 - Completed
  Kidney Failure, Chronic
  
• Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
  ClinicalTrials.gov Identifier: NCT00078195 - Completed
  Hay Fever; Hypersensitivity; Allergy; Rhinitis
  
• Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00264849 - Recruiting
  Asthma
  
• Omalizumab to Treat Eosinophilic Gastroenteritis
  ClinicalTrials.gov Identifier: NCT00084097 - Active, not recruiting
  Gastroenteritis
  
• Omalizumab to Treat Hyper-IgE (Job's) Syndrome
  ClinicalTrials.gov Identifier: NCT00260702 - Recruiting
  Hyper-IgE Syndrome; Job's Syndrome
  
• Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00567476 - Recruiting
  Asthma
  
• Omega 3 Fatty Acids and Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00508248 - Recruiting
  Atrial Fibrillation
  
• Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
  ClinicalTrials.gov Identifier: NCT00467818 - Recruiting
  Autism
  
• Omega 3 PUFAs and Microvolt TWA in Patients With Ventricular Arrhythmia
  ClinicalTrials.gov Identifier: NCT00507390 - Recruiting
  Defibrillators, Implantable
  
• Omega Interferon Alone or in Combination with Ribavirin in Subjects with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00097045 - Completed
  Hepatitis C
  
• Omega-3 and Vitamin E Supplementation in Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00399282 - Completed
  Rheumatoid Arthritis
  
• Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment
  ClinicalTrials.gov Identifier: NCT00558532 - Recruiting
  Morbid Obesity; Cardiovascular Disease; Fatty Acid Levels
  
• Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies
  ClinicalTrials.gov Identifier: NCT00135902 - Active, not recruiting
  Preterm Birth; Pregnancy
  
• Omega-3 Fatty Acid Treatment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00360906 - Completed
  Relapsing-Remitting Multiple Sclerosis
  
• Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery
  ClinicalTrials.gov Identifier: NCT00488904 - Recruiting
  Complications; Infections; Colorectal Cancer
  
• Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00511810 - Recruiting
  Major Depressive Disorder; Neuroimaging
  
• Omega-3 Fatty Acids for High Triglycerides in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00346697 - Recruiting
  HIV; AIDS; Dyslipidemia; Hypertriglyceridemia
  
• Omega-3 Fatty Acids for Treating Adults With Major Depression
  ClinicalTrials.gov Identifier: NCT00517036 - Recruiting
  Depression
  
• Omega-3 Fatty Acids in Adolescent Depression
  ClinicalTrials.gov Identifier: NCT00312897 - Recruiting
  Adolescent Depression
  
• Omega-3 fatty acids in bipolar disorder
  ClinicalTrials.gov Identifier: NCT00010868 - Completed
  Bipolar Disorder
  
• Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00252486 - Active, not recruiting
  Bipolar Disorder
  
• Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00114296 - Active, not recruiting
  Breast Cancer
  
• Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00001146 - Completed
  Bipolar Disorder; Involutional Depression; Mood Disorder
  
• Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
  ClinicalTrials.gov Identifier: NCT00003077 - Completed
  Leukemia; Lymphoma; Multiple Myeloma
  
• Omega-3 Fatty Acids that Affect the Immune System in Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00047983 - Completed
  Kidney Diseases
  
• Omega-3 for Depression and Other Cardiac Risk Factors
  ClinicalTrials.gov Identifier: NCT00116857 - Recruiting
  Cardiovascular Diseases; Depression; Heart Diseases; Myocardial Infarction; Angina, Unstable
  
• Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00149409 - Recruiting
  Chronic Heart Failure
  
• Omega-Three Fatty Acids for the Prevention of Atrial Fibrillation After Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00446966 - Recruiting
  Atrial Fibrillation
  
• OmegAD (Omega-3 and Alzheimer's Disease)
  ClinicalTrials.gov Identifier: NCT00211159 - Completed
  Alzheimer's Disease
  
• Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.
  ClinicalTrials.gov Identifier: NCT00172198 - Recruiting
  Critical Ill Patients in SICU
  
• Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)
  ClinicalTrials.gov Identifier: NCT00412256 - Completed
  Rheumatoid Arthritis
  
• Omentectomy for the Treatment of Diabetes Mellitus Type 2
  ClinicalTrials.gov Identifier: NCT00270439 - Active, not recruiting
  Diabetes Mellitus Type 2; Dyslipidemia; Hypercholesterolemia; Obesity
  
• Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
  ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
  Gastric Cancer; Precancerous Condition
  
• Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-Adjusted Dosing
  ClinicalTrials.gov Identifier: NCT00537732 - Recruiting
  Gastroesophageal Reflux
  
• OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
  ClinicalTrials.gov Identifier: NCT00277524 - Active, not recruiting
  Tachycardia, Ventricular; Heart Failure, Congestive; Ventricular Fibrillation; Ventricular Dysfunction; Bradycardia
  
• Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
  ClinicalTrials.gov Identifier: NCT00478556 - Recruiting
  Healthy
  
• Omr-IgG-am™ (Trademark) for Treating Patients with or at High Risk for West Nile Virus Disease
  ClinicalTrials.gov Identifier: NCT00069316 - Active, not recruiting
  West Nile Virus
  
• On Demand Treatment of Reflux Disease
  ClinicalTrials.gov Identifier: NCT00184522 - Completed
  Gastroesophageal Reflux
  
• On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
  ClinicalTrials.gov Identifier: NCT00564460 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
  ClinicalTrials.gov Identifier: NCT00161096 - Active, not recruiting
  Chronic Use of Acid Suppressive Medication; GORD; GERD; Reflux; Peptic Ulcer
  
• Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
  ClinicalTrials.gov Identifier: NCT00256828 - Completed
  HIV Infections
  
• Once Daily 3TC, Efavirenz and ddI for HIV Infection
  ClinicalTrials.gov Identifier: NCT00214435 - Recruiting
  HIV Infection; AIDS
  
• Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART
  ClinicalTrials.gov Identifier: NCT00196612 - Completed
  HIV Infections
  
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00413374 - Recruiting
  Deep Vein Thrombosis; Pulmonary Embolism
  
• Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00343850 - Terminated
  Ulcerative Colitis
  
• Once Weekly Parathyroid Hormone for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00065637 - Completed
  Osteopenia; Osteoporosis
  
• Once Weekly Radiation for Lung Cancer With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00256789 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Once-A-Month Steroid Treatment for Patients with Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00004990 - Completed
  Glomerulonephritis; Nephrotic Syndrome
  
• Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children
  ClinicalTrials.gov Identifier: NCT00129688 - Completed
  Neutropenia; Cancer; Fever
  
• Once-Daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
  ClinicalTrials.gov Identifier: NCT00532168 - Recruiting
  HIV Infections
  
• Once-Daily Drug Regimen for HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001968 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infections
  
• Once-Daily HAART Regimen Administration in HIV-1 Infected Children in Burkina Faso
  ClinicalTrials.gov Identifier: NCT00122538 - Active, not recruiting
  HIV Infection; AIDS
  
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
  ClinicalTrials.gov Identifier: NCT00289198 - Completed
  Perennial Allergic Rhinitis
  
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
  ClinicalTrials.gov Identifier: NCT00197262 - Active, not recruiting
  Rhinitis
  
• Once-Daily Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis. The Einstein-DVT Dose-Finding Study
  ClinicalTrials.gov Identifier: NCT00395772 - Completed
  Treatment of Venous Thromboembolism
  
• Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
  ClinicalTrials.gov Identifier: NCT00084136 - Active, not recruiting
  HIV Infections
  
• ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
  ClinicalTrials.gov Identifier: NCT00003034 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• OncoVEX GM-CSF in Patients With Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00402025 - Recruiting
  Pancreatic Cancer
  
• Ondansetron for the Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00033085 - Active, not recruiting
  Cocaine-Related Disorders; Drug Administration Schedule
  
• Ondansetron for the Treatment of Methamphetamine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00040053 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00006348 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
  
• Ondansetron Reduce Vomiting Associated With Ketamine PSA
  ClinicalTrials.gov Identifier: NCT00387556 - Completed
  Conscious Sedation
  
• Ondansetron Treatment for Alcoholism
  ClinicalTrials.gov Identifier: NCT00000443 - Completed
  Alcoholism
  
• Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
  ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
  
• One Hour Preoperative Gatifloxacin
  ClinicalTrials.gov Identifier: NCT00350363 - Recruiting
  Ophthalmic Surgery
  
• One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine
  ClinicalTrials.gov Identifier: NCT00142337 - Active, not recruiting
  HIV; Postpartum Period
  
• One Tablet Sublingual Immunotherapy in Adults with Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00146991 - Terminated
  Seasonal Allergic Rhinoconjunctivitis
  
• One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00358397 - Recruiting
  Tumors
  
• One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
  ClinicalTrials.gov Identifier: NCT00465855 - Recruiting
  Carbon Monoxide Poisoning
  
• One Week PTHrP IV Dose Escalation Study
  ClinicalTrials.gov Identifier: NCT00580788 - Not yet recruiting
  Osteoporosis; Humoral Hypercalcemia of Malignancy; Hyperparathyroidism
  
• One Year Drug Treatment in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159081 - Active, not recruiting
  Schizophrenia
  
• One Year Extension Study To Protocol C2/5/TZ:MS-05
  ClinicalTrials.gov Identifier: NCT00464958 - Not yet recruiting
  Spasticity; Fatigue
  
• One Year Glargine Treatment in CFRD Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00483769 - Completed
  Cystic Fibrosis; Glucose Metabolism Disorders
  
• One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00409851 - Completed
  Hypertension
  
• One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
  ClinicalTrials.gov Identifier: NCT00246467 - Active, not recruiting
  Plague
  
• One-Lung Ventilation: Expression of Pulmonary Inflammatory Mediators
  ClinicalTrials.gov Identifier: NCT00515905 - Recruiting
  Thoracic Surgery With One-Lung Ventilation
  
• One-Year Prospective Observational Study of BMI Change Effect of 5-Alpha Reductase Inhibitor in Korean BPH Patients
  ClinicalTrials.gov Identifier: NCT00472251 - Recruiting
  Benign Prostatic Hyperplasia
  
• Onercept in the Treatment and Re-Treatment of Subjects with Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00090129 - Terminated
  Psoriatic Arthritis
  
• Online Caregiver Psychoeducation and Support for Alzheimer's
  ClinicalTrials.gov Identifier: NCT00416078 - Recruiting
  Alzheimer's Disease
  
• Online Family Support and Education for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00046085 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Online HIV Prevention Vignette Evaluation
  ClinicalTrials.gov Identifier: NCT00249327 - Completed
  HIV Infections
  
• Online Survey on Computer Password Usage
  ClinicalTrials.gov Identifier: NCT00357136 - Recruiting
  Carpal Tunnel Syndrome
  
• ONO-7436 Phase II Study in Japan
  ClinicalTrials.gov Identifier: NCT00212602 - Completed
  Malignant Tumor
  
• Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-Release) As Add-on Therapy To L-Dopa In Parkinson's
  ClinicalTrials.gov Identifier: NCT00363727 - Active, not recruiting
  Parkinson's Disease; Dyskinesias
  
• Onsite versus Referral Models of Primary Care for Substance Abusing Patients
  ClinicalTrials.gov Identifier: NCT00057096 - Completed
  Substance Abuse
  
• OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
  ClinicalTrials.gov Identifier: NCT00439127 - Completed
  Differentiated Thyroid Carcinoma
  
• Ontak (Denileukin Diftitox) in Patients With SM
  ClinicalTrials.gov Identifier: NCT00493129 - Completed
  Leukemia; Systemic Mastocytosis
  
• ONTAK to Estimate Response in Cutaneous T-Cell Lymphoma According to CD25 Status
  ClinicalTrials.gov Identifier: NCT00279396 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
  ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
  Cardiovascular Diseases
  
• Ontario ICU Clinical Best Practices Demonstration Project
  ClinicalTrials.gov Identifier: NCT00332982 - Completed
  Ventilator Acquired Pneumonia; Catheter Related Blood Stream Infections; Pressure Ulcer Prophylaxis; DVT Prophylaxis; Restrictive Blood Transfusion Strategy; Daily Spontaeous Breathing Trials
  
• Ontario MDCT Coronary Angiography Study (OMCAS)
  ClinicalTrials.gov Identifier: NCT00371891 - Recruiting
  Coronary Arteriosclerosis; Cardiomyopathies; Heart Defects, Congenital; Heart Valve Diseases
  
• Onychomycosis: Diagnosis and Prevalence in Diabetic Neuropathic Patients
  ClinicalTrials.gov Identifier: NCT00525187 - Completed
  Prevalence of Onychomycosis; Diabetic Neuropathic Patients; Diagnostic of Onychomycosis; Patients Clinically Suspected of Onychomycosis; Reliability of the Diagnosis of Onychomycosis
  
• ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006106 - Recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• OPAL - Insulin Glulisine, Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00272012 - Completed
  Diabetes Mellitus Type 2
  
• OPALS Cardiac Arrest Database (OCAD)
  ClinicalTrials.gov Identifier: NCT00300703 - Recruiting
  Cardiac Arrest
  
• OPALS Critical Care Sub-Studies
  ClinicalTrials.gov Identifier: NCT00212953 - Active, not recruiting
  Cardiac Arrest
  
• OPALS Pediatric Study
  ClinicalTrials.gov Identifier: NCT00298532 - Active, not recruiting
  Seizure
  
• Open Label Arimidex in Gynecomastia
  ClinicalTrials.gov Identifier: NCT00241436 - Completed
  Gynecomastia
  
• Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00432653 - Not yet recruiting
  Ankylosing Spondylitis
  
• Open Label Comparative Study on Celecoxib Efficacy and Safety vs Non-Selective NSAID in Acute Pain Due to Ankle Sprain
  ClinicalTrials.gov Identifier: NCT00446797 - Recruiting
  Sprains and Strains
  
• Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
  ClinicalTrials.gov Identifier: NCT00311649 - Active, not recruiting
  Influenza
  
• Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
  ClinicalTrials.gov Identifier: NCT00148330 - Active, not recruiting
  Diabetic macular oedema
  
• Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00477594 - Recruiting
  Familial Hypercholesterolemia
  
• Open Label Extension Study Evaluating Sildenafil Citrate When Used In Combination with Epoprostenol In PAH
  ClinicalTrials.gov Identifier: NCT00147641 - Active, not recruiting
  Pulmonary Hypertension
  
• Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00440037 - Recruiting
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00116688 - Recruiting
  Thrombocytopenia
  
• Open Label Extension Study of Bifeprunox
  ClinicalTrials.gov Identifier: NCT00366171 - Completed
  Schizophrenia
  
• Open Label Extension Study of Eculizumab in Patients with Transfusion Dependent PNH.
  ClinicalTrials.gov Identifier: NCT00122317 - Active, not recruiting
  Transfusion dependent, hemolytic paroxysmal nocturnal hemoglobinuria.
  
• Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00139594 - Completed
  Bipolar Disorder
  
• Open Label Extension Study to Evaluate the Long Term Use of Valsartan in 1-5 Year Old Hypertensive Children
  ClinicalTrials.gov Identifier: NCT00457626 - Recruiting
  Hypertension
  
• Open Label Extension Trial for Rotigotine in Advanced Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00501969 - Active, not recruiting
  Advanced Parkinson's Disease
  
• Open Label Follow up Trial of Rotigotine in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00505687 - Active, not recruiting
  Parkinson's Disease
  
• Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
  ClinicalTrials.gov Identifier: NCT00002025 - Completed
  Cytomegalovirus Infections; Cytomegalovirus Retinitis; HIV Infections
  
• Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00260793 - Recruiting
  Parkinson's Disease
  
• Open Label INCB018424 in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00509899 - Recruiting
  Myelofibrosis; Polycythemia Vera; Thrombocytosis
  
• Open Label Long Term Follow up Study With Certolizumab Pegol for Patients Completing C87042
  ClinicalTrials.gov Identifier: NCT00333788 - Recruiting
  Crohn Disease
  
• Open Label Long-Term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
  ClinicalTrials.gov Identifier: NCT00526071 - Recruiting
  Fabry Disease
  
• Open Label Long-Term Safety Study of CDP870 (Certolizumab Pegol) for Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00160693 - Active, not recruiting
  Rheumatoid Arthritis
  
• Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00280956 - Completed
  Crohn's Disease
  
• Open Label Non-Comparative Clinical Trial of Tigecycline in Patients With Catheter Infection
  ClinicalTrials.gov Identifier: NCT00419991 - Recruiting
  Staphylococcal Infections
  
• Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer
  ClinicalTrials.gov Identifier: NCT00582985 - Recruiting
  Cancer; Neoplasm Metastasis
  
• Open Label Phase 3 Study of NABI-IGIV 10% [(HUMAN)] In Subjects With Primary Immune Deficiency Disorders (PIDD)
  ClinicalTrials.gov Identifier: NCT00538915 - Recruiting
  Primary Immune Deficiency Disorders; Antibody Deficiency Syndromes
  
• Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00280397 - Recruiting
  Cancer
  
• Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
  ClinicalTrials.gov Identifier: NCT00407498 - Recruiting
  Neoplasm
  
• Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00000695 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Open Label Phase III Duloxetine Study for Stress Urinary Incontinence
  ClinicalTrials.gov Identifier: NCT00191204 - Completed
  Urinary Incontinence Stress
  
• Open Label Randomized Neoadjuvant Chemotherapy (Paclitaxel Followed by FEC) Versus Paclitaxel and RAD001 Followed by FEC in Women With Triple Receptor-Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00499603 - Recruiting
  Breast Cancer
  
• Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00160628 - Completed
  Epilepsy, Partial
  
• Open Label Safety and Efficacy Study of Levetiracetam in Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00160654 - Completed
  Epilepsy, Partial
  
• Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With HIV Neuropathy
  ClinicalTrials.gov Identifier: NCT00264875 - Recruiting
  Peripheral Neuropathy; HIV
  
• Open Label Safety Efficacy Study of Levetiracetam in Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00152373 - Completed
  Epilepsy, Partial
  
• Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients with Refractory Epilepsy.
  ClinicalTrials.gov Identifier: NCT00175864 - Not yet recruiting
  Epilepsy
  
• Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
  ClinicalTrials.gov Identifier: NCT00330785 - Completed
  Hypertension; Dyslipidemia
  
• Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms.
  ClinicalTrials.gov Identifier: NCT00553449 - Active, not recruiting
  Heartburn; Gastroesophageal Reflux
  
• Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00432068 - Recruiting
  Healthy
  
• Open Label Study of Adalimumab in Subjects Who Have a Sub-Optimal Response to Systemic Therapy or Phototherapy
  ClinicalTrials.gov Identifier: NCT00566722 - Not yet recruiting
  Psoriasis
  
• Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
  ClinicalTrials.gov Identifier: NCT00425230 - Recruiting
  Chronic Phantom Limb Pain
  
• Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
  Bipolar Disorder
  
• Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting
  ClinicalTrials.gov Identifier: NCT00509990 - Completed
  Atopic Dermatitis
  
• Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00034658 - Completed
  Mycoses
  
• Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00034632 - Completed
  Mycoses
  
• Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole
  ClinicalTrials.gov Identifier: NCT00237224 - Terminated
  Breast Cancer
  
• Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00454207 - Recruiting
  Pulmonary Hypertension
  
• Open Label Study of Subcutaneous Homoharringtonine in Patients With Advanced CML
  ClinicalTrials.gov Identifier: NCT00462943 - Recruiting
  Chronic Myelogenous Leukemia
  
• Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm
  ClinicalTrials.gov Identifier: NCT00397670 - Completed
  Contraception
  
• Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
  ClinicalTrials.gov Identifier: NCT00298818 - Active, not recruiting
  Epilepsy; Mental Retardation; Developmental Disabilities
  
• Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
  ClinicalTrials.gov Identifier: NCT00174304 - Completed
  Hypertension; Hyperlipidemia
  
• Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250 µg in Patients of Chinese Origin With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00370071 - Recruiting
  Multiple Sclerosis
  
• Open Label Study to Evaluate the Safety of Twice Daily Oral Carvedilol
  ClinicalTrials.gov Identifier: NCT00129363 - Active, not recruiting
  Congestive Heart Failure
  
• Open Label Study with